Europe PMCopen access
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany
Neurocritical Care, Eculizumab, Myasthenic Crisis, Ravulizumab, C5‐inhibition
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 120118
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.